Read the latest blogs by our professional diabetes educators and experts on the latest and most important healthcare topics.
Re-focusing on a Healthier Lifestyle — The Brain-Gut ConnectionFriday,February 1, 2023
Is a way we can re-focus and “train” our brains to help us deal with issues related to weight and […]
Assessing Weight: Pounds, Percent or Inches?Friday,February 1, 2023
Assessing Weight: Pounds, Percent or Inches? Given the health risks associated with being overweight or having obesity, and because many […]
Afrezza: Will it revolutionize insulin therapy?Friday,February 13, 2015
The FDA approved the inhaled insulin, Afrezza, last summer, and it will likely undergo a massive marketing campaign to providers and possibly to people with diabetes directly. Here is some important clinical trial information about the medicine and how it is indicated for use in patients.
Overcoming Medication Adherence ChallengesFriday,February 20, 2015
Diabetes educator Debbie Berg discusses some strategies to make it easier to keep up with your regular regimen of medicine.
A New Treatment for Diabetic RetinopathyFriday,March 11, 2015
The FDA recently approved Lucentis for use of diabetic retinopathy. Pharmacist and certified diabetes educator Sam Grossman talks about the clinical trial results for the new drug and considerations of how people with the complication may want to consider talking to their provider about it.
A New Long-Acting Insulin OptionFriday,April 17, 2015
Sanofi's recently approved insulin, Toujeo, is 300u/ml and offers clinicians and people with diabetes who have glycemic control issues another long-acting insulin. Sam Grossman discusses some of the studies' findings.